1 Study Coverage
    1.1 Neuro-Oncological Diseases Device Product Introduction
    1.2 Market by Type
        1.2.1 Global Neuro-Oncological Diseases Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 MRI
        1.2.3 CT Scan
        1.2.4 PET
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Neuro-Oncological Diseases Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Diagnostics Centers
        1.3.5 Reference Laboratories
        1.3.6 Medical Research Institutes
        1.3.7 Others
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Neuro-Oncological Diseases Device Sales Estimates and Forecasts 2017-2028
    2.2 Global Neuro-Oncological Diseases Device Revenue Estimates and Forecasts 2017-2028
    2.3 Global Neuro-Oncological Diseases Device Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Neuro-Oncological Diseases Device Sales by Region
        2.4.1 Global Neuro-Oncological Diseases Device Sales by Region (2017-2022)
        2.4.2 Global Sales Neuro-Oncological Diseases Device by Region (2023-2028)
    2.5 Global Neuro-Oncological Diseases Device Revenue by Region
        2.5.1 Global Neuro-Oncological Diseases Device Revenue by Region (2017-2022)
        2.5.2 Global Neuro-Oncological Diseases Device Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Neuro-Oncological Diseases Device Sales by Manufacturers
        3.1.1 Global Top Neuro-Oncological Diseases Device Manufacturers by Sales (2017-2022)
        3.1.2 Global Neuro-Oncological Diseases Device Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Neuro-Oncological Diseases Device in 2021
    3.2 Global Neuro-Oncological Diseases Device Revenue by Manufacturers
        3.2.1 Global Neuro-Oncological Diseases Device Revenue by Manufacturers (2017-2022)
        3.2.2 Global Neuro-Oncological Diseases Device Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Neuro-Oncological Diseases Device Revenue in 2021
    3.3 Global Neuro-Oncological Diseases Device Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Neuro-Oncological Diseases Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Neuro-Oncological Diseases Device Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Neuro-Oncological Diseases Device Sales by Type
        4.1.1 Global Neuro-Oncological Diseases Device Historical Sales by Type (2017-2022)
        4.1.2 Global Neuro-Oncological Diseases Device Forecasted Sales by Type (2023-2028)
        4.1.3 Global Neuro-Oncological Diseases Device Sales Market Share by Type (2017-2028)
    4.2 Global Neuro-Oncological Diseases Device Revenue by Type
        4.2.1 Global Neuro-Oncological Diseases Device Historical Revenue by Type (2017-2022)
        4.2.2 Global Neuro-Oncological Diseases Device Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Neuro-Oncological Diseases Device Revenue Market Share by Type (2017-2028)
    4.3 Global Neuro-Oncological Diseases Device Price by Type
        4.3.1 Global Neuro-Oncological Diseases Device Price by Type (2017-2022)
        4.3.2 Global Neuro-Oncological Diseases Device Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Neuro-Oncological Diseases Device Sales by Application
        5.1.1 Global Neuro-Oncological Diseases Device Historical Sales by Application (2017-2022)
        5.1.2 Global Neuro-Oncological Diseases Device Forecasted Sales by Application (2023-2028)
        5.1.3 Global Neuro-Oncological Diseases Device Sales Market Share by Application (2017-2028)
    5.2 Global Neuro-Oncological Diseases Device Revenue by Application
        5.2.1 Global Neuro-Oncological Diseases Device Historical Revenue by Application (2017-2022)
        5.2.2 Global Neuro-Oncological Diseases Device Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Neuro-Oncological Diseases Device Revenue Market Share by Application (2017-2028)
    5.3 Global Neuro-Oncological Diseases Device Price by Application
        5.3.1 Global Neuro-Oncological Diseases Device Price by Application (2017-2022)
        5.3.2 Global Neuro-Oncological Diseases Device Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Neuro-Oncological Diseases Device Market Size by Type
        6.1.1 North America Neuro-Oncological Diseases Device Sales by Type (2017-2028)
        6.1.2 North America Neuro-Oncological Diseases Device Revenue by Type (2017-2028)
    6.2 North America Neuro-Oncological Diseases Device Market Size by Application
        6.2.1 North America Neuro-Oncological Diseases Device Sales by Application (2017-2028)
        6.2.2 North America Neuro-Oncological Diseases Device Revenue by Application (2017-2028)
    6.3 North America Neuro-Oncological Diseases Device Market Size by Country
        6.3.1 North America Neuro-Oncological Diseases Device Sales by Country (2017-2028)
        6.3.2 North America Neuro-Oncological Diseases Device Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Neuro-Oncological Diseases Device Market Size by Type
        7.1.1 Europe Neuro-Oncological Diseases Device Sales by Type (2017-2028)
        7.1.2 Europe Neuro-Oncological Diseases Device Revenue by Type (2017-2028)
    7.2 Europe Neuro-Oncological Diseases Device Market Size by Application
        7.2.1 Europe Neuro-Oncological Diseases Device Sales by Application (2017-2028)
        7.2.2 Europe Neuro-Oncological Diseases Device Revenue by Application (2017-2028)
    7.3 Europe Neuro-Oncological Diseases Device Market Size by Country
        7.3.1 Europe Neuro-Oncological Diseases Device Sales by Country (2017-2028)
        7.3.2 Europe Neuro-Oncological Diseases Device Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Neuro-Oncological Diseases Device Market Size by Type
        8.1.1 Asia Pacific Neuro-Oncological Diseases Device Sales by Type (2017-2028)
        8.1.2 Asia Pacific Neuro-Oncological Diseases Device Revenue by Type (2017-2028)
    8.2 Asia Pacific Neuro-Oncological Diseases Device Market Size by Application
        8.2.1 Asia Pacific Neuro-Oncological Diseases Device Sales by Application (2017-2028)
        8.2.2 Asia Pacific Neuro-Oncological Diseases Device Revenue by Application (2017-2028)
    8.3 Asia Pacific Neuro-Oncological Diseases Device Market Size by Region
        8.3.1 Asia Pacific Neuro-Oncological Diseases Device Sales by Region (2017-2028)
        8.3.2 Asia Pacific Neuro-Oncological Diseases Device Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Neuro-Oncological Diseases Device Market Size by Type
        9.1.1 Latin America Neuro-Oncological Diseases Device Sales by Type (2017-2028)
        9.1.2 Latin America Neuro-Oncological Diseases Device Revenue by Type (2017-2028)
    9.2 Latin America Neuro-Oncological Diseases Device Market Size by Application
        9.2.1 Latin America Neuro-Oncological Diseases Device Sales by Application (2017-2028)
        9.2.2 Latin America Neuro-Oncological Diseases Device Revenue by Application (2017-2028)
    9.3 Latin America Neuro-Oncological Diseases Device Market Size by Country
        9.3.1 Latin America Neuro-Oncological Diseases Device Sales by Country (2017-2028)
        9.3.2 Latin America Neuro-Oncological Diseases Device Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Neuro-Oncological Diseases Device Market Size by Type
        10.1.1 Middle East and Africa Neuro-Oncological Diseases Device Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Neuro-Oncological Diseases Device Revenue by Type (2017-2028)
    10.2 Middle East and Africa Neuro-Oncological Diseases Device Market Size by Application
        10.2.1 Middle East and Africa Neuro-Oncological Diseases Device Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Neuro-Oncological Diseases Device Revenue by Application (2017-2028)
    10.3 Middle East and Africa Neuro-Oncological Diseases Device Market Size by Country
        10.3.1 Middle East and Africa Neuro-Oncological Diseases Device Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Neuro-Oncological Diseases Device Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Siemens Healthcare
        11.1.1 Siemens Healthcare Corporation Information
        11.1.2 Siemens Healthcare Overview
        11.1.3 Siemens Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Siemens Healthcare Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Siemens Healthcare Recent Developments
    11.2 Philips Healthcare
        11.2.1 Philips Healthcare Corporation Information
        11.2.2 Philips Healthcare Overview
        11.2.3 Philips Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Philips Healthcare Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Philips Healthcare Recent Developments
    11.3 Canon Medical Systems
        11.3.1 Canon Medical Systems Corporation Information
        11.3.2 Canon Medical Systems Overview
        11.3.3 Canon Medical Systems Neuro-Oncological Diseases Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Canon Medical Systems Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Canon Medical Systems Recent Developments
    11.4 GE Healthcare
        11.4.1 GE Healthcare Corporation Information
        11.4.2 GE Healthcare Overview
        11.4.3 GE Healthcare Neuro-Oncological Diseases Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 GE Healthcare Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 GE Healthcare Recent Developments
    11.5 Hitachi Medical
        11.5.1 Hitachi Medical Corporation Information
        11.5.2 Hitachi Medical Overview
        11.5.3 Hitachi Medical Neuro-Oncological Diseases Device Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Hitachi Medical Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Hitachi Medical Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Neuro-Oncological Diseases Device Industry Chain Analysis
    12.2 Neuro-Oncological Diseases Device Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Neuro-Oncological Diseases Device Production Mode & Process
    12.4 Neuro-Oncological Diseases Device Sales and Marketing
        12.4.1 Neuro-Oncological Diseases Device Sales Channels
        12.4.2 Neuro-Oncological Diseases Device Distributors
    12.5 Neuro-Oncological Diseases Device Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Neuro-Oncological Diseases Device Industry Trends
    13.2 Neuro-Oncological Diseases Device Market Drivers
    13.3 Neuro-Oncological Diseases Device Market Challenges
    13.4 Neuro-Oncological Diseases Device Market Restraints
14 Key Findings in The Global Neuro-Oncological Diseases Device Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Neuro-Oncological Diseases Device Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of MRI
    Table 3. Major Manufacturers of CT Scan
    Table 4. Major Manufacturers of PET
    Table 5. Major Manufacturers of Others
    Table 6. Global Neuro-Oncological Diseases Device Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 7. Global Neuro-Oncological Diseases Device Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 8. Global Neuro-Oncological Diseases Device Sales by Region (2017-2022) & (Units)
    Table 9. Global Neuro-Oncological Diseases Device Sales Market Share by Region (2017-2022)
    Table 10. Global Neuro-Oncological Diseases Device Sales by Region (2023-2028) & (Units)
    Table 11. Global Neuro-Oncological Diseases Device Sales Market Share by Region (2023-2028)
    Table 12. Global Neuro-Oncological Diseases Device Revenue by Region (2017-2022) & (US$ Million)
    Table 13. Global Neuro-Oncological Diseases Device Revenue Market Share by Region (2017-2022)
    Table 14. Global Neuro-Oncological Diseases Device Revenue by Region (2023-2028) & (US$ Million)
    Table 15. Global Neuro-Oncological Diseases Device Revenue Market Share by Region (2023-2028)
    Table 16. Global Neuro-Oncological Diseases Device Sales by Manufacturers (2017-2022) & (Units)
    Table 17. Global Neuro-Oncological Diseases Device Sales Share by Manufacturers (2017-2022)
    Table 18. Global Neuro-Oncological Diseases Device Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 19. Global Neuro-Oncological Diseases Device Revenue Share by Manufacturers (2017-2022)
    Table 20. Neuro-Oncological Diseases Device Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 21. Global Neuro-Oncological Diseases Device Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 22. Global Neuro-Oncological Diseases Device by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuro-Oncological Diseases Device as of 2021)
    Table 23. Neuro-Oncological Diseases Device Manufacturing Base Distribution and Headquarters
    Table 24. Manufacturers Neuro-Oncological Diseases Device Product Offered
    Table 25. Date of Manufacturers Enter into Neuro-Oncological Diseases Device Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Neuro-Oncological Diseases Device Sales by Type (2017-2022) & (Units)
    Table 28. Global Neuro-Oncological Diseases Device Sales by Type (2023-2028) & (Units)
    Table 29. Global Neuro-Oncological Diseases Device Sales Share by Type (2017-2022)
    Table 30. Global Neuro-Oncological Diseases Device Sales Share by Type (2023-2028)
    Table 31. Global Neuro-Oncological Diseases Device Revenue by Type (2017-2022) & (US$ Million)
    Table 32. Global Neuro-Oncological Diseases Device Revenue by Type (2023-2028) & (US$ Million)
    Table 33. Global Neuro-Oncological Diseases Device Revenue Share by Type (2017-2022)
    Table 34. Global Neuro-Oncological Diseases Device Revenue Share by Type (2023-2028)
    Table 35. Neuro-Oncological Diseases Device Price by Type (2017-2022) & (USD/Unit)
    Table 36. Global Neuro-Oncological Diseases Device Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 37. Global Neuro-Oncological Diseases Device Sales by Application (2017-2022) & (Units)
    Table 38. Global Neuro-Oncological Diseases Device Sales by Application (2023-2028) & (Units)
    Table 39. Global Neuro-Oncological Diseases Device Sales Share by Application (2017-2022)
    Table 40. Global Neuro-Oncological Diseases Device Sales Share by Application (2023-2028)
    Table 41. Global Neuro-Oncological Diseases Device Revenue by Application (2017-2022) & (US$ Million)
    Table 42. Global Neuro-Oncological Diseases Device Revenue by Application (2023-2028) & (US$ Million)
    Table 43. Global Neuro-Oncological Diseases Device Revenue Share by Application (2017-2022)
    Table 44. Global Neuro-Oncological Diseases Device Revenue Share by Application (2023-2028)
    Table 45. Neuro-Oncological Diseases Device Price by Application (2017-2022) & (USD/Unit)
    Table 46. Global Neuro-Oncological Diseases Device Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 47. North America Neuro-Oncological Diseases Device Sales by Type (2017-2022) & (Units)
    Table 48. North America Neuro-Oncological Diseases Device Sales by Type (2023-2028) & (Units)
    Table 49. North America Neuro-Oncological Diseases Device Revenue by Type (2017-2022) & (US$ Million)
    Table 50. North America Neuro-Oncological Diseases Device Revenue by Type (2023-2028) & (US$ Million)
    Table 51. North America Neuro-Oncological Diseases Device Sales by Application (2017-2022) & (Units)
    Table 52. North America Neuro-Oncological Diseases Device Sales by Application (2023-2028) & (Units)
    Table 53. North America Neuro-Oncological Diseases Device Revenue by Application (2017-2022) & (US$ Million)
    Table 54. North America Neuro-Oncological Diseases Device Revenue by Application (2023-2028) & (US$ Million)
    Table 55. North America Neuro-Oncological Diseases Device Sales by Country (2017-2022) & (Units)
    Table 56. North America Neuro-Oncological Diseases Device Sales by Country (2023-2028) & (Units)
    Table 57. North America Neuro-Oncological Diseases Device Revenue by Country (2017-2022) & (US$ Million)
    Table 58. North America Neuro-Oncological Diseases Device Revenue by Country (2023-2028) & (US$ Million)
    Table 59. Europe Neuro-Oncological Diseases Device Sales by Type (2017-2022) & (Units)
    Table 60. Europe Neuro-Oncological Diseases Device Sales by Type (2023-2028) & (Units)
    Table 61. Europe Neuro-Oncological Diseases Device Revenue by Type (2017-2022) & (US$ Million)
    Table 62. Europe Neuro-Oncological Diseases Device Revenue by Type (2023-2028) & (US$ Million)
    Table 63. Europe Neuro-Oncological Diseases Device Sales by Application (2017-2022) & (Units)
    Table 64. Europe Neuro-Oncological Diseases Device Sales by Application (2023-2028) & (Units)
    Table 65. Europe Neuro-Oncological Diseases Device Revenue by Application (2017-2022) & (US$ Million)
    Table 66. Europe Neuro-Oncological Diseases Device Revenue by Application (2023-2028) & (US$ Million)
    Table 67. Europe Neuro-Oncological Diseases Device Sales by Country (2017-2022) & (Units)
    Table 68. Europe Neuro-Oncological Diseases Device Sales by Country (2023-2028) & (Units)
    Table 69. Europe Neuro-Oncological Diseases Device Revenue by Country (2017-2022) & (US$ Million)
    Table 70. Europe Neuro-Oncological Diseases Device Revenue by Country (2023-2028) & (US$ Million)
    Table 71. Asia Pacific Neuro-Oncological Diseases Device Sales by Type (2017-2022) & (Units)
    Table 72. Asia Pacific Neuro-Oncological Diseases Device Sales by Type (2023-2028) & (Units)
    Table 73. Asia Pacific Neuro-Oncological Diseases Device Revenue by Type (2017-2022) & (US$ Million)
    Table 74. Asia Pacific Neuro-Oncological Diseases Device Revenue by Type (2023-2028) & (US$ Million)
    Table 75. Asia Pacific Neuro-Oncological Diseases Device Sales by Application (2017-2022) & (Units)
    Table 76. Asia Pacific Neuro-Oncological Diseases Device Sales by Application (2023-2028) & (Units)
    Table 77. Asia Pacific Neuro-Oncological Diseases Device Revenue by Application (2017-2022) & (US$ Million)
    Table 78. Asia Pacific Neuro-Oncological Diseases Device Revenue by Application (2023-2028) & (US$ Million)
    Table 79. Asia Pacific Neuro-Oncological Diseases Device Sales by Region (2017-2022) & (Units)
    Table 80. Asia Pacific Neuro-Oncological Diseases Device Sales by Region (2023-2028) & (Units)
    Table 81. Asia Pacific Neuro-Oncological Diseases Device Revenue by Region (2017-2022) & (US$ Million)
    Table 82. Asia Pacific Neuro-Oncological Diseases Device Revenue by Region (2023-2028) & (US$ Million)
    Table 83. Latin America Neuro-Oncological Diseases Device Sales by Type (2017-2022) & (Units)
    Table 84. Latin America Neuro-Oncological Diseases Device Sales by Type (2023-2028) & (Units)
    Table 85. Latin America Neuro-Oncological Diseases Device Revenue by Type (2017-2022) & (US$ Million)
    Table 86. Latin America Neuro-Oncological Diseases Device Revenue by Type (2023-2028) & (US$ Million)
    Table 87. Latin America Neuro-Oncological Diseases Device Sales by Application (2017-2022) & (Units)
    Table 88. Latin America Neuro-Oncological Diseases Device Sales by Application (2023-2028) & (Units)
    Table 89. Latin America Neuro-Oncological Diseases Device Revenue by Application (2017-2022) & (US$ Million)
    Table 90. Latin America Neuro-Oncological Diseases Device Revenue by Application (2023-2028) & (US$ Million)
    Table 91. Latin America Neuro-Oncological Diseases Device Sales by Country (2017-2022) & (Units)
    Table 92. Latin America Neuro-Oncological Diseases Device Sales by Country (2023-2028) & (Units)
    Table 93. Latin America Neuro-Oncological Diseases Device Revenue by Country (2017-2022) & (US$ Million)
    Table 94. Latin America Neuro-Oncological Diseases Device Revenue by Country (2023-2028) & (US$ Million)
    Table 95. Middle East and Africa Neuro-Oncological Diseases Device Sales by Type (2017-2022) & (Units)
    Table 96. Middle East and Africa Neuro-Oncological Diseases Device Sales by Type (2023-2028) & (Units)
    Table 97. Middle East and Africa Neuro-Oncological Diseases Device Revenue by Type (2017-2022) & (US$ Million)
    Table 98. Middle East and Africa Neuro-Oncological Diseases Device Revenue by Type (2023-2028) & (US$ Million)
    Table 99. Middle East and Africa Neuro-Oncological Diseases Device Sales by Application (2017-2022) & (Units)
    Table 100. Middle East and Africa Neuro-Oncological Diseases Device Sales by Application (2023-2028) & (Units)
    Table 101. Middle East and Africa Neuro-Oncological Diseases Device Revenue by Application (2017-2022) & (US$ Million)
    Table 102. Middle East and Africa Neuro-Oncological Diseases Device Revenue by Application (2023-2028) & (US$ Million)
    Table 103. Middle East and Africa Neuro-Oncological Diseases Device Sales by Country (2017-2022) & (Units)
    Table 104. Middle East and Africa Neuro-Oncological Diseases Device Sales by Country (2023-2028) & (Units)
    Table 105. Middle East and Africa Neuro-Oncological Diseases Device Revenue by Country (2017-2022) & (US$ Million)
    Table 106. Middle East and Africa Neuro-Oncological Diseases Device Revenue by Country (2023-2028) & (US$ Million)
    Table 107. Siemens Healthcare Corporation Information
    Table 108. Siemens Healthcare Description and Major Businesses
    Table 109. Siemens Healthcare Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 110. Siemens Healthcare Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 111. Siemens Healthcare Recent Developments
    Table 112. Philips Healthcare Corporation Information
    Table 113. Philips Healthcare Description and Major Businesses
    Table 114. Philips Healthcare Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 115. Philips Healthcare Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Philips Healthcare Recent Developments
    Table 117. Canon Medical Systems Corporation Information
    Table 118. Canon Medical Systems Description and Major Businesses
    Table 119. Canon Medical Systems Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 120. Canon Medical Systems Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Canon Medical Systems Recent Developments
    Table 122. GE Healthcare Corporation Information
    Table 123. GE Healthcare Description and Major Businesses
    Table 124. GE Healthcare Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 125. GE Healthcare Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. GE Healthcare Recent Developments
    Table 127. Hitachi Medical Corporation Information
    Table 128. Hitachi Medical Description and Major Businesses
    Table 129. Hitachi Medical Neuro-Oncological Diseases Device Sales (Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 130. Hitachi Medical Neuro-Oncological Diseases Device Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Hitachi Medical Recent Developments
    Table 132. Key Raw Materials Lists
    Table 133. Raw Materials Key Suppliers Lists
    Table 134. Neuro-Oncological Diseases Device Distributors List
    Table 135. Neuro-Oncological Diseases Device Customers List
    Table 136. Neuro-Oncological Diseases Device Market Trends
    Table 137. Neuro-Oncological Diseases Device Market Drivers
    Table 138. Neuro-Oncological Diseases Device Market Challenges
    Table 139. Neuro-Oncological Diseases Device Market Restraints
    Table 140. Research Programs/Design for This Report
    Table 141. Key Data Information from Secondary Sources
    Table 142. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neuro-Oncological Diseases Device Product Picture
    Figure 3. Global Neuro-Oncological Diseases Device Market Share by Type in 2021 & 2028
    Figure 3. MRI Product Picture
    Figure 4. CT Scan Product Picture
    Figure 5. PET Product Picture
    Figure 6. Others Product Picture
    Figure 7. Global Neuro-Oncological Diseases Device Market Share by Application in 2021 & 2028
    Figure 8. Hospitals
    Figure 9. Clinics
    Figure 10. Diagnostics Centers
    Figure 11. Reference Laboratories
    Figure 12. Medical Research Institutes
    Figure 13. Others
    Figure 14. Neuro-Oncological Diseases Device Report Years Considered
    Figure 15. Global Neuro-Oncological Diseases Device Sales 2017-2028 (Units)
    Figure 16. Global Neuro-Oncological Diseases Device Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 17. Global Neuro-Oncological Diseases Device Revenue 2017-2028 (US$ Million)
    Figure 18. Global Neuro-Oncological Diseases Device Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 19. Global Neuro-Oncological Diseases Device Sales Market Share by Region (2017-2022)
    Figure 20. Global Neuro-Oncological Diseases Device Sales Market Share by Region (2023-2028)
    Figure 21. North America Neuro-Oncological Diseases Device Sales YoY (2017-2028) & (Units)
    Figure 22. North America Neuro-Oncological Diseases Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Neuro-Oncological Diseases Device Sales YoY (2017-2028) & (Units)
    Figure 24. Europe Neuro-Oncological Diseases Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. Asia-Pacific Neuro-Oncological Diseases Device Sales YoY (2017-2028) & (Units)
    Figure 26. Asia-Pacific Neuro-Oncological Diseases Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 27. Latin America Neuro-Oncological Diseases Device Sales YoY (2017-2028) & (Units)
    Figure 28. Latin America Neuro-Oncological Diseases Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 29. Middle East & Africa Neuro-Oncological Diseases Device Sales YoY (2017-2028) & (Units)
    Figure 30. Middle East & Africa Neuro-Oncological Diseases Device Revenue YoY (2017-2028) & (US$ Million)
    Figure 31. The Neuro-Oncological Diseases Device Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 32. The Top 5 and 10 Largest Manufacturers of Neuro-Oncological Diseases Device in the World: Market Share by Neuro-Oncological Diseases Device Revenue in 2021
    Figure 33. Global Neuro-Oncological Diseases Device Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 34. Global Neuro-Oncological Diseases Device Sales Market Share by Type (2017-2028)
    Figure 35. Global Neuro-Oncological Diseases Device Revenue Market Share by Type (2017-2028)
    Figure 36. Global Neuro-Oncological Diseases Device Sales Market Share by Application (2017-2028)
    Figure 37. Global Neuro-Oncological Diseases Device Revenue Market Share by Application (2017-2028)
    Figure 38. North America Neuro-Oncological Diseases Device Sales Market Share by Type (2017-2028)
    Figure 39. North America Neuro-Oncological Diseases Device Revenue Market Share by Type (2017-2028)
    Figure 40. North America Neuro-Oncological Diseases Device Sales Market Share by Application (2017-2028)
    Figure 41. North America Neuro-Oncological Diseases Device Revenue Market Share by Application (2017-2028)
    Figure 42. North America Neuro-Oncological Diseases Device Sales Share by Country (2017-2028)
    Figure 43. North America Neuro-Oncological Diseases Device Revenue Share by Country (2017-2028)
    Figure 44. U.S. Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 45. Canada Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 46. Europe Neuro-Oncological Diseases Device Sales Market Share by Type (2017-2028)
    Figure 47. Europe Neuro-Oncological Diseases Device Revenue Market Share by Type (2017-2028)
    Figure 48. Europe Neuro-Oncological Diseases Device Sales Market Share by Application (2017-2028)
    Figure 49. Europe Neuro-Oncological Diseases Device Revenue Market Share by Application (2017-2028)
    Figure 50. Europe Neuro-Oncological Diseases Device Sales Share by Country (2017-2028)
    Figure 51. Europe Neuro-Oncological Diseases Device Revenue Share by Country (2017-2028)
    Figure 52. Germany Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 53. France Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 54. U.K. Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 55. Italy Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 56. Russia Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 57. Asia Pacific Neuro-Oncological Diseases Device Sales Market Share by Type (2017-2028)
    Figure 58. Asia Pacific Neuro-Oncological Diseases Device Revenue Market Share by Type (2017-2028)
    Figure 59. Asia Pacific Neuro-Oncological Diseases Device Sales Market Share by Application (2017-2028)
    Figure 60. Asia Pacific Neuro-Oncological Diseases Device Revenue Market Share by Application (2017-2028)
    Figure 61. Asia Pacific Neuro-Oncological Diseases Device Sales Share by Region (2017-2028)
    Figure 62. Asia Pacific Neuro-Oncological Diseases Device Revenue Share by Region (2017-2028)
    Figure 63. China Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 64. Japan Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 65. South Korea Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 66. India Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 67. Australia Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 68. Taiwan Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 69. Indonesia Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 70. Thailand Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 71. Malaysia Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 72. Philippines Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 73. Latin America Neuro-Oncological Diseases Device Sales Market Share by Type (2017-2028)
    Figure 74. Latin America Neuro-Oncological Diseases Device Revenue Market Share by Type (2017-2028)
    Figure 75. Latin America Neuro-Oncological Diseases Device Sales Market Share by Application (2017-2028)
    Figure 76. Latin America Neuro-Oncological Diseases Device Revenue Market Share by Application (2017-2028)
    Figure 77. Latin America Neuro-Oncological Diseases Device Sales Share by Country (2017-2028)
    Figure 78. Latin America Neuro-Oncological Diseases Device Revenue Share by Country (2017-2028)
    Figure 79. Mexico Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 80. Brazil Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 81. Argentina Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 82. Middle East and Africa Neuro-Oncological Diseases Device Sales Market Share by Type (2017-2028)
    Figure 83. Middle East and Africa Neuro-Oncological Diseases Device Revenue Market Share by Type (2017-2028)
    Figure 84. Middle East and Africa Neuro-Oncological Diseases Device Sales Market Share by Application (2017-2028)
    Figure 85. Middle East and Africa Neuro-Oncological Diseases Device Revenue Market Share by Application (2017-2028)
    Figure 86. Middle East and Africa Neuro-Oncological Diseases Device Sales Share by Country (2017-2028)
    Figure 87. Middle East and Africa Neuro-Oncological Diseases Device Revenue Share by Country (2017-2028)
    Figure 88. Turkey Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 89. Saudi Arabia Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 90. UAE Neuro-Oncological Diseases Device Revenue (2017-2028) & (US$ Million)
    Figure 91. Neuro-Oncological Diseases Device Value Chain
    Figure 92. Neuro-Oncological Diseases Device Production Process
    Figure 93. Channels of Distribution
    Figure 94. Distributors Profiles
    Figure 95. Bottom-up and Top-down Approaches for This Report
    Figure 96. Data Triangulation
    Figure 97. Key Executives Interviewed